Leadership and Core Faculty

Our Team
Dave L. Dixon, PharmD

Center Director and Associate Professor

Research Interests: Lipid disorders, Hypertension, Diabetes, Chronic heart failure, Pharmacist-Physician Collaborative Practice Models

Teresa M. Salgado
Teresa M. Salgado, MPharm, PhD

Assistant Director and Assistant Professor

Research Interests: Pharmacists’ roles in improving medication use and health outcomes in primary care, Pharmacists’ roles in the management of patients with chronic kidney disease, Drug information for health care professionals

Gary R. Matzke
Gary R. Matzke, PharmD, FCCP, FCP

Founding Director, AACP/ASHP/VC Congressional Health Care Policy Fellow Program, Emeritus Professor

Research Interests: Public Policy, Nephrology, Chronic Kidney Disease, Drug Development, Regulatory Science

David A. Holdford
David A. Holdford, PhD

Professor

Research Interests: Applied Pharmacoeconomics, Pharmacist Entrepreneurship, Marketing Pharmacist Services and Pharmaceuticals, Health Outcomes

Evan M. Sisson
Evan M. Sisson, PharmD, MSHA, BCACP, CDE, FAADE

Associate Professor

Research Interests: Primary Care, Diabetes, Dyslipidemia

Kristin Zimmerman
Kristin Zimmerman, PharmD, CGP

Associate Professor

Research Interests: Medication Regimen Complexity, De-Prescribing, Geriatrics, Cognition

John D Bucheit
John D Bucheit, PharmD, CDE, BCACP

Assistant Professor

Research Interests: Hypertensive Urgency, Chronotherapy, Diabetes, Interprofessional Education

Lauren Grecheck
Lauren G. Pamulapati, PharmD, BCACP

Assistant Professor

Research Interests: Diabetes, Transitions of Care, Telehealth, Practice Advancement, and Post-Graduate Training for Pharmacy Students

Dayanjan (Shanaka) Wijesinghe
Dayanjan (Shanaka) Wijesinghe

Assistant Professor

japatterson2
Julie Patterson, PharmD, PhD

Assistant Professor

Samuel G. Johnson, PharmD, BCPS, FCCP

Associate Executive Director Board of Pharmacy Specialties (BPS)

Research Interests: Assessing the impact and value of board certification for pharmacist specialists; Assessing the effects of innovative clinical pharmacy services on clinical and economic outcomes; and Advancement of clinical pharmacy practice to improve sustainability, quality, and value for patients and the public